Bosl GJ - Search Results

1

Hormone-secreting metastatic interstitial cell tumor of the testis.

Schwarzman MI, Russo P, Bosl GJ, Whitmore WF Jr. Schwarzman MI, et al. Among authors: bosl gj. J Urol. 1989 Mar;141(3):620-2. doi: 10.1016/s0022-5347(17)40917-7. J Urol. 1989. PMID: 2918605

2

Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.

Wood DP Jr, Herr HW, Heller G, Vlamis V, Sogani PC, Motzer RJ, Fair WR, Bosl GJ. Wood DP Jr, et al. Among authors: bosl gj. J Urol. 1992 Dec;148(6):1812-5; discussion 1815-6. doi: 10.1016/s0022-5347(17)37036-2. J Urol. 1992. PMID: 1331547

3

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.

Wood DP Jr, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ. Wood DP Jr, et al. Among authors: bosl gj. Cancer. 1992 Nov 1;70(9):2354-7. doi: 10.1002/1097-0142(19921101)70:9<2354::aid-cncr2820700924>3.0.co;2-u. Cancer. 1992. PMID: 1382832

4

Assessment of risk in metastatic testis carcinoma: impact on treatment.

Bajorin DF, Geller NL, Bosl GJ. Bajorin DF, et al. Among authors: bosl gj. Urol Int. 1991;46(3):298-303. doi: 10.1159/000282155. Urol Int. 1991. PMID: 1656578 Review.

5

Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Motzer RJ, Geller NL, Tan CC, Herr H, Morse M, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ. Motzer RJ, et al. Among authors: bosl gj. Cancer. 1991 Mar 1;67(5):1305-10. doi: 10.1002/1097-0142(19910301)67:5<1305::aid-cncr2820670506>3.0.co;2-j. Cancer. 1991. PMID: 1703917 Clinical Trial.

6

Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.

Herr HW, Toner GC, Geller NL, Bosl GJ. Herr HW, et al. Among authors: bosl gj. Eur Urol. 1991;19(1):1-5. doi: 10.1159/000473567. Eur Urol. 1991. PMID: 1848821

7

The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982).

Israel A, Bosl GJ, Golbey RB, Whitmore W Jr, Martini N. Israel A, et al. Among authors: bosl gj. J Clin Oncol. 1985 Aug;3(8):1073-8. doi: 10.1200/JCO.1985.3.8.1073. J Clin Oncol. 1985. PMID: 2410574

8

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.

Bosl GJ, Gluckman R, Geller NL, Golbey RB, Whitmore WF Jr, Herr H, Sogani P, Morse M, Martini N, Bains M, et al. Bosl GJ, et al. J Clin Oncol. 1986 Oct;4(10):1493-9. doi: 10.1200/JCO.1986.4.10.1493. J Clin Oncol. 1986. PMID: 2428948 Clinical Trial.

9

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.

Bosl GJ, Geller NL, Vogelzang NJ, Carey R, Auman J, Whitmore WF, Herr H, Morse M, Sogani P, Chan E. Bosl GJ, et al. J Clin Oncol. 1987 Mar;5(3):436-40. doi: 10.1200/JCO.1987.5.3.436. J Clin Oncol. 1987. PMID: 2434627

10

Advanced seminoma: the role of chemotherapy and adjunctive surgery.

Motzer RJ, Bosl GJ, Geller NL, Penenberg D, Yagoda A, Golbey R, Whitmore WF Jr, Fair WR, Sogani P, Herr H, et al. Motzer RJ, et al. Among authors: bosl gj. Ann Intern Med. 1988 Apr;108(4):513-8. doi: 10.7326/0003-4819-108-4-513. Ann Intern Med. 1988. PMID: 2450500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters